Intec Pharma Ltd. (NTEC)’s Financial Results Comparing With Cellular Biomedicine Group Inc. (NASDAQ:CBMG)

This is therefore a contrasting of the institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations in Intec Pharma Ltd. (NASDAQ:NTEC) and Cellular Biomedicine Group Inc. (NASDAQ:CBMG). The two are both Biotechnology companies that compete with one another.

Earnings Valuation

Table 1 demonstrates Intec Pharma Ltd. and Cellular Biomedicine Group Inc.’s top-line revenue, earnings per share (EPS) and valuation.

Profitability

Table 2 represents Intec Pharma Ltd. (NASDAQ:NTEC) and Cellular Biomedicine Group Inc. (NASDAQ:CBMG)’s return on assets, net margins and return on equity.

Analyst Recommendations

Intec Pharma Ltd. and Cellular Biomedicine Group Inc. Ratings and Recommendations are available in the next table.

Competitively Cellular Biomedicine Group Inc. has an average price target of $26, with potential upside of 51.69%.

Institutional and Insider Ownership

The shares of both Intec Pharma Ltd. and Cellular Biomedicine Group Inc. are owned

... read more at: https://moveefy.com/2019/04/15/intec-pharma-ltd-ntecs-financial-results-comparing-with-cellular-biomedicine-group-inc-nasdaqcbmg/

by

Leave a Reply